	US 12,116,514 B2
	Curable composition, film, laminated body, and display apparatus
Yoshifumi Komatsu, Osaka (JP); and Yoshihiro Harada, Osaka (JP)
Assigned to SUMITOMO CHEMICAL COMPANY, LIMITED, Tokyo (JP)
Appl. No. 17/284,034
Filed by SUMITOMO CHEMICAL COMPANY, LIMITED, Tokyo (JP)
PCT Filed Oct. 15, 2019, PCT No. PCT/JP2019/040402 § 371(c)(1), (2) Date Apr. 9, 2021, PCT Pub. No. WO2020/090430, PCT Pub. Date May 7, 2020.
Claims priority of application No. 2018-205894 (JP), filed on Oct. 31, 2018.
Prior Publication US 2021/0380879 A1, Dec. 9, 2021
Int. Cl. C09K 11/06 (2006.01); B82Y 30/00 (2011.01); C08F 2/48 (2006.01); C08F 20/06 (2006.01); C08J 5/18 (2006.01); C09K 11/02 (2006.01)

CPC C09K 11/06 (2013.01) [C08F 2/48 (2013.01); C08F 20/06 (2013.01); C08J 5/18 (2013.01); C09K 11/02 (2013.01); B82Y 30/00 (2013.01); C08J 2333/10 (2013.01); C09K 2211/10 (2013.01)]

6 Claims

1. A curable composition comprising a fluorescent particle (A) containing a perovskite compound, a photopolymerizable compound (B), and a photopolymerization initiator (C),

wherein the following expression (I) is satisfied:

5.0×10⁻⁶≤(Ab_C×M_C)/M_A≤1.0 (I)

wherein M_A[% by mass] represents a content of the fluorescent particle (A) and M_C[% by mass] represents a content of the photopolymerization initiator (C) in 100% by mass of a solid content of the curable composition, and Ab_Crepresents an absorbance of the photopolymerization initiator (C) at a wavelength of 365 nm and at a concentration of 1 mg/100 mL.